Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents

Ubaldina Galli; Cristina Travelli; Silvio Aprile; Elena Arrigoni; Simone Torretta; Giorgio Grosa; Alberto Massarotti; Giovanni Sorba; Pier Luigi Canonico; Armando A. Genazzani; Gian Cesare Tron

doi:10.1021/jm5016389

Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents

Ubaldina Galli
, Cristina Travelli
, Silvio Aprile
, Elena Arrigoni
, Simone Torretta
, Giorgio Grosa
, Alberto Massarotti
, Giovanni Sorba
, Pier Luigi Canonico
, Armando A. Genazzani
, Gian Cesare Tron

Dipartimento di Scienze del Farmaco

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

In the present manuscript, starting from the 1,4-benzodiazepin-2-one nucleus, a privileged structure in medicinal chemistry, we have synthesized a novel class of cis-locked combretastatins named combreatabenzodiazepines. They show similar cytotoxic and antitubulin activity compared to combretastatin A-4 in neuroblastoma cells, showing a better pharmacokinetic profile. This class of compounds has therefore the potential for further development as antitubulin agents.

Lingua originale	Inglese
pagine (da-a)	1345-1357
Numero di pagine	13
Rivista	Journal of Medicinal Chemistry
Volume	58
Numero di pubblicazione	3
DOI	https://doi.org/10.1021/jm5016389
Stato di pubblicazione	Pubblicato - 12 feb 2015

Accesso al documento

10.1021/jm5016389

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{f605a8e05ba74c63b170264c1461ddd6,

title = "Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents",

abstract = "In the present manuscript, starting from the 1,4-benzodiazepin-2-one nucleus, a privileged structure in medicinal chemistry, we have synthesized a novel class of cis-locked combretastatins named combreatabenzodiazepines. They show similar cytotoxic and antitubulin activity compared to combretastatin A-4 in neuroblastoma cells, showing a better pharmacokinetic profile. This class of compounds has therefore the potential for further development as antitubulin agents.",

author = "Ubaldina Galli and Cristina Travelli and Silvio Aprile and Elena Arrigoni and Simone Torretta and Giorgio Grosa and Alberto Massarotti and Giovanni Sorba and Canonico, \{Pier Luigi\} and Genazzani, \{Armando A.\} and Tron, \{Gian Cesare\}",

note = "Publisher Copyright: {\textcopyright} 2015 American Chemical Society.",

year = "2015",

month = feb,

day = "12",

doi = "10.1021/jm5016389",

language = "English",

volume = "58",

pages = "1345--1357",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "3",

}

TY - JOUR

T1 - Design, synthesis, and biological evaluation of combretabenzodiazepines

T2 - A novel class of anti-tubulin agents

AU - Galli, Ubaldina

AU - Travelli, Cristina

AU - Aprile, Silvio

AU - Arrigoni, Elena

AU - Torretta, Simone

AU - Grosa, Giorgio

AU - Massarotti, Alberto

AU - Sorba, Giovanni

AU - Canonico, Pier Luigi

AU - Genazzani, Armando A.

AU - Tron, Gian Cesare

PY - 2015/2/12

Y1 - 2015/2/12

N2 - In the present manuscript, starting from the 1,4-benzodiazepin-2-one nucleus, a privileged structure in medicinal chemistry, we have synthesized a novel class of cis-locked combretastatins named combreatabenzodiazepines. They show similar cytotoxic and antitubulin activity compared to combretastatin A-4 in neuroblastoma cells, showing a better pharmacokinetic profile. This class of compounds has therefore the potential for further development as antitubulin agents.

AB - In the present manuscript, starting from the 1,4-benzodiazepin-2-one nucleus, a privileged structure in medicinal chemistry, we have synthesized a novel class of cis-locked combretastatins named combreatabenzodiazepines. They show similar cytotoxic and antitubulin activity compared to combretastatin A-4 in neuroblastoma cells, showing a better pharmacokinetic profile. This class of compounds has therefore the potential for further development as antitubulin agents.

UR - https://www.scopus.com/pages/publications/84922769004

U2 - 10.1021/jm5016389

DO - 10.1021/jm5016389

M3 - Article

SN - 0022-2623

VL - 58

SP - 1345

EP - 1357

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 3

ER -

Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents

Abstract

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo